Stay updated on OpACIN-neo Optimal Combo Trial
Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.

Latest updates to the OpACIN-neo Optimal Combo Trial page
- CheckyesterdayChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- Added the Nat Med 2026 PRADO-trial publication: Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis (Nat Med, 2026 Mar;32(3):952-963; Epub 2026 Jan 28). - Removed the earlier Nat Med ahead-of-print citation (Nat Med, 2026 Jan 28).SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-facing content changes were observed on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedAdministrative updates: a new system revision (v3.4.2) is added, and older notices (including a funding-lapse alert and revision v3.4.1) are removed. These changes do not alter study details.SummaryDifference0.4%

- Check73 days agoChange DetectedAdded an administrative funding notice and a 2026 Nat Med publication citation to Publications, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to OpACIN-neo Optimal Combo Trial
Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.